Aims: Free iron plays an important role in the pathogenesis of acute kidney injury (AKI) via the formation of hydroxyl radicals. Systemic iron homeostasis is controlled by the hemojuvelin-hepcidin-ferroportin axis in the liver, but less is known about this role in AKI. Results: By proteomics, we identified a 42 kDa soluble hemojuvelin (sHJV), processed by furin protease from membrane-bound hemojuvelin (mHJV), in the urine during AKI after cardiac surgery. Biopsies from human and mouse specimens with AKI confirm that HJV is extensively increased in renal tubules. Iron overload enhanced the expression of hemojuvelin-hepcidin signaling pathway. The furin inhibitor (FI) decreases furin-mediated proteolytic cleavage of mHJV into sHJV and augments the mHJV/sHJV ratio after iron overload with hypoxia condition. The FI could reduce renal tubule apoptosis, stabilize hypoxic induced factor-1, prevent the accumulation of iron in the kidney, and further ameliorate ischemic-reperfusion injury. mHJV is associated with decreasing total kidney iron, secreting hepcidin, and promoting the degradation of ferroportin at AKI, whereas sHJV does the opposite. Innovation: This study suggests the ratio of mHJV/sHJV affects the iron deposition during acute kidney injury and sHJV could be an early biomarker of AKI. Conclusion: Our findings link endogenous HJV inextricably with renal iron homeostasis for the first time, add new significance to early predict AKI, and identify novel therapeutic targets to reduce the severity of AKI using the FI. Antioxid. Redox Signal. 20, 1181–1194.
Get full access to this article
View all access options for this article.
References
1.
BabittJL, HuangFW, XiaY, SidisY, AndrewsNC, and LinHY. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J Clin Invest, 117: 1933–1939, 2007.
2.
BaligaR, UedaN, and ShahSV. Increase in bleomycin-detectable iron in ischemia-reperfusion injury to rat kidneys. Biochem J, 291: 901–905, 1993.
3.
BaligaR, ZhangZW, BaligaM, and ShahSV. Evidence for cytochrome P-450 as a source of catalytic iron in myoglobinuric acute renal failure. Kidney Int, 49: 362–369, 1996.
4.
This reference has been deleted.
5.
BaligaR, ZhangZW, and ShahSV. Role of cytochrome P-450 in hydrogen peroxide-induced cytotoxicity to LLC-PK1 cells. Kidney Int, 50: 1118–1124, 1996.
CocaSG. Acute kidney injury in elderly persons. Am J Kidney Dis, 56: 122–131, 2010.
8.
DevarajanP, KrawczeskiCD, NguyenMT, KathmanT, WangZ, and ParikhCR. Proteomic identification of early biomarkers of acute kidney injury after cardiac surgery in children. Am J Kidney Dis, 56: 632–642, 2010.
9.
DuffieldJS, ParkKM, HsiaoLL, KelleyVR, ScaddenDT, IchimuraT, and BonventreJV. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest, 115: 1743–1755, 2005.
10.
El-AchkarTM, WuXR, RauchmanM, McCrackenR, KieferS, and DagherPC. Tamm-Horsfall protein protects the kidney from ischemic injury by decreasing inflammation and altering TLR4 expression. Am J Physiol Renal Physiol 295: F53, 4–F544, 2008.
11.
HaaseM, BellomoR, and Haase-FielitzA. Novel biomarkers, oxidative stress, and the role of labile iron toxicity in cardiopulmonary bypass-associated acute kidney injury. J Am Coll Cardiol, 55: 2024–2033, 2010.
12.
HalliwellB and GutteridgeJMC. Role of free-radicals and catalytic metal-ions in human-disease—an overview. Method Enzymol, 186: 1–85, 1990.
13.
HardingC, HeuserJ, and StahlP. Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J Cell Biol, 97: 329–339, 1983.
14.
HoJ, LucyM, KrokhinO, HayglassK, PascoeE, DarrochG, RushD, NickersonP, RigattoC, and ReslerovaM. Mass spectrometry-based proteomic analysis of urine in acute kidney injury following cardiopulmonary bypass: a nested case-control study. Am J Kidney Dis, 53: 584–595, 2009.
15.
HuangFW, PinkusJL, PinkusGS, FlemingMD, and AndrewsNC. A mouse model of juvenile hemochromatosis. J Clin Invest, 115: 2187–2191, 2005.
IshizakaN, SaitoK, FurutaK, MatsuzakiG, KoikeK, NoiriE, and NagaiR. Angiotensin II-induced regulation of the expression and localization of iron metabolism-related genes in the rat kidney. Hypertens Res, 30: 195–202, 2007.
18.
KingstonHM and JassieLB. Microwave acid sample decomposition for elemental analysis. J Res Natl Inst Stan, 93: 269–274, 1988.
19.
LeeIN, ChenCH, SheuJC, LeeHS, HuangGT, ChenDS, YuCY, WenCL, LuFJ, and ChowLP. Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach. Proteomics, 6: 2865–2873, 2006.
20.
LinL, GoldbergYP, and GanzT. Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin. Blood, 106: 2884–2889, 2005.
21.
McMahonS, GrondinF, McDonaldPP, RichardDE, and DuboisCM. Hypoxia-enhanced expression of the proprotein convertase furin is mediated by hypoxia-inducible factor-1: impact on the bioactivation of proproteins. J Biol Chem, 280: 6561–6569, 2005.
22.
MehtaRL, KellumJA, ShahSV, MolitorisBA, RoncoC, WarnockDG, and LevinA. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care, 11: R31, 2007.
23.
MoriK, LeeHT, RapoportD, DrexlerIR, FosterK, YangJ, Schmidt-OttKM, ChenX, LiJY, WeissS, MishraJ, CheemaFH, MarkowitzG, SuganamiT, SawaiK, MukoyamaM, KunisC, D'AgatiV, DevarajanP, and BaraschJ. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest, 115: 610–621, 2005.
24.
MoriguchiJ, EzakiT, TsukaharaT, FurukiK, FukuiY, OkamotoS, UkaiH, SakuraiH, ShimboS, and IkedaM. Comparative evaluation of four urinary tubular dysfunction markers, with special references to the effects of aging and correction for creatinine concentration. Toxicol Lett, 143: 279–290, 2003.
25.
NiederkoflerV, SalieR, and ArberS. Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. J Clin Invest, 115: 2180–2186, 2005.
26.
PallerMS and HedlundBE. Role of iron in postischemic renal injury in the rat. Kidney Int, 34: 474–480, 1988.
27.
PerinL, SedrakyanS, GiulianiS, Da SaccoS, CarraroG, ShiriL, LemleyKV, RosolM, WuS, AtalaA, WarburtonD, and De FilippoRE. Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis. PLoS One, 5: e9357, 2010.
28.
Rodriguez MartinezA, NiemelaO, and ParkkilaS. Hepatic and extrahepatic expression of the new iron regulatory protein hemojuvelin. Haematologica, 89: 1441–1445, 2004.
29.
RyanMJ, JohnsonG, KirkJ, FuerstenbergSM, ZagerRA, and Torok-StorbB. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int, 45: 48–57, 1994.
30.
SaracMS, CameronA, and LindbergI. The furin inhibitor hexa-D-arginine blocks the activation of Pseudomonas aeruginosa exotoxin A in vivo. Infect Immun, 70: 7136–7139, 2002.
31.
SaracMS, PeinadoJR, LepplaSH, and LindbergI. Protection against anthrax toxemia by hexa-D-arginine in vitro and in vivo. Infect Immun, 72: 602–605, 2004.
32.
This reference has been deleted.
33.
SilvestriL, PaganiA, and CamaschellaC. Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis. Blood, 111: 924–931, 2008.
34.
SilvestriL, PaganiA, FaziC, GerardiG, LeviS, ArosioP, and CamaschellaC. Defective targeting of hemojuvelin to plasma membrane is a common pathogenetic mechanism in juvenile hemochromatosis. Blood, 109: 4503–4510, 2007.
35.
VincentSH, GradyRW, ShaklaiN, SniderJM, and Muller-EberhardU. The influence of heme-binding proteins in heme-catalyzed oxidations. Arch Biochem Biophys, 265: 539–550, 1988.
36.
WaikarSS, LiuKD, and ChertowGM. Diagnosis, epidemiology and outcomes of acute kidney injury. Clin J Am Soc Nephrol, 3: 844–861, 2008.
37.
WalkerPD and ShahSV. Evidence suggesting a role for hydroxyl radical in gentamicin-induced acute renal failure in rats. J Clin Invest, 81: 334–341, 1988.
WuVC, KoWJ, ChangHW, ChenYS, ChenYW, ChenYM, HuFC, LinYH, TsaiPR, and WuKD. Early renal replacement therapy in patients with postoperative acute liver failure associated with acute renal failure: Effect on postoperative outcomes. J Am Coll Surgeons, 205: 266–276, 2007.
40.
WuVC, KoWJ, ChangHW, ChenYW, LinYF, ShiaoCC, ChenYM, ChenYS, TsaiPR, HuFC, WangJY, LinYH, WuKD, and Re NTUSIA. Risk factors of early redialysis after weaning from postoperative acute renal replacement therapy. Intensive Care Med, 34: 101–108, 2008.
41.
WuVC, LoSC, ChenYL, HuangPH, TsaiCT, LiangCJ, KuoCC, KuoYS, LeeBC, WuEL, LinYH, SunYY, LinSL, ChenJW, LinSJ, WuKD, and GrpTS. Endothelial progenitor cells in primary aldosteronism: a biomarker of severity for aldosterone vasculopathy and prognosis. J Clin Endocrinol Metab, 96: 3175–3183, 2011.
42.
WuVC, WangCH, WangWJ, LinYF, HuFC, ChenYW, ChenYS, WuMS, LinYH, KuoCC, HuangTM, ChenYM, TsaiPR, KoWJ, WuKD, and GrpNS. Sustained low-efficiency dialysis versus continuous veno-venous hemofiltration for postsurgical acute renal failure. Am J Surg, 199: 466–476, 2010.
43.
WuVC, YoungGH, HuangPH, LoSC, WangKC, SunCY, LiangCJ, HuangTM, ChenJH, ChangFC, ChenYL, KuoYS, ChenJB, ChenJW, ChenYM, KoWJ, WuKD, The Ng. In acute kidney injury, indoxyl sulfate impairs human endothelial progenitor cells: modulation by statin. Angiogenesis, 16: 609–6242013.
44.
ZhangAS, WestAPJr., WymanAE, BjorkmanPJ, and EnnsCA. Interaction of hemojuvelin with neogenin results in iron accumulation in human embryonic kidney 293 cells. J Biol Chem, 280: 33885–33894, 2005.
45.
ZhangAS, YangF, WangJ, TsukamotoH, and EnnsCA. Hemojuvelin-neogenin interaction is required for bone morphogenic protein-4-induced hepcidin expression. J Biol Chem, 284: 22580–22589, 2009.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
